Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

Early-stage / Active MDL55 eventsMedical Device

AngioDynamics Port Catheter

Medical Device · claims involving AngioDynamics and Navilyst implanted port catheter devices including SmartPort, Xcela, BioFlo, and Vortex with alleged fracture, migration, infection, and thrombosis risks

Defendant

AngioDynamics, Inc.

MDL / Track

MDL 3125

S.D. Cal.

Judge

Judge Jinsook Ohta

Plaintiffs

~365 pending (344 per JPML's March 2, 2026 report, plus ~21 new filings tracked since)

Bellwether / Trial

No verdicts yet

Settlement Status

  • No global settlement announced as of mid-2026
  • litigation remains in early pretrial with bellwether trials not expected before 2028
Home/Torts/AngioDynamics Port Catheter
SharePost on XShare on BlueskyShare on LinkedInShare on FacebookEmail

Track litigations for free. Save this matter, capture notes, and monitor live signals.

Sign in
← Torts Case overview Litigation status Geographic exposure Key defendants Timeline Statute of limitations Live activity News PubMed openFDA Court filings

Case overview

MDL 3125, In re AngioDynamics, Inc. and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, is pending before Judge Jinsook Ohta in the Southern District of California with approximately 300+ cases. Bellwether selection is underway with 18-case pools due August 2026 and trials expected mid-2028. The litigation covers SmartPort, Vortex, BioFlo, and Xcela devices.

Causation Theory

Plaintiffs allege excessive barium sulfate concentrations in polyurethane catheter tubing create irregular surfaces with fissures, pits, and cracks that increase biofilm formation risk and cause catheter fracture. The FDA issued Class I recalls of SmartPort kits in February 2021 and Vortex MP Port in September 2022. Fractured fragments migrate to heart and lungs, causing bloodstream infections, sepsis, deep vein thrombosis, and death.

Case Management Orders

Litigation status

MDL 3125 before Judge Jinsook Ohta in S.D. Cal. remains in early pretrial proceedings with bellwether selection underway. Court granted 60-day extension requiring each side to submit nine representative cases by August 4, 2026, narrowing to four each by December 11, 2026 for final pool of eight trial claims; first bellwether trial unlikely before mid-2028.

MDL Track

MDL 3125

S.D. Cal.

AngioDynamics/Navilyst port catheter products liability

344 pending

State Court Activity

Limited state court activity; primary litigation concentrated in MDL 3125

Geographic exposure

MDL 3125 consolidated in C.D. Cal. Five-state concentration (CA, TX, FL, NY, PA) represents majority of filed cases involving SmartPort, Xcela, BioFlo, and Vortex devices.

  • California

    MDL 3125 centralized in Central District of California. State with highest plaintiff concentration in AngioDynamics port catheter litigation per court filings.

  • Texas

    Second-highest plaintiff concentration in MDL 3125. Tort reform limits certain damage awards.

  • Florida

    Third-highest plaintiff concentration. Tort reform limits certain damage awards.

  • New York

    Fourth-highest plaintiff concentration. Generally allows broader recovery under state product liability law.

  • Pennsylvania

    Fifth-highest plaintiff concentration in MDL 3125.

Key defendants

AngioDynamics, Inc.

Role: Manufacturer

Pending MDL 3125 centralization. Alabama ruling (Apr 2024) applied Comment k to defective design claims but preserved failure-to-warn AEMLD claims. Aggressive personal jurisdiction defense posture shown in D. Mass dismissals (Walters, 21-cv-1122; Mora, 21-cv-11352).

Navilyst Medical, Inc.

Role: Subsidiary

Wholly-owned subsidiary with operations controlled from AngioDynamics' New York headquarters. Named alongside parent in port-catheter complaints; jurisdictional dismissals granted based on New York principal place of business.

DefendantRoleIntelligence Note
AngioDynamics, Inc.ManufacturerPending MDL 3125 centralization. Alabama ruling (Apr 2024) applied Comment k to defective design claims but preserved failure-to-warn AEMLD claims. Aggressive personal jurisdiction defense posture shown in D. Mass dismissals (Walters, 21-cv-1122; Mora, 21-cv-11352).
Navilyst Medical, Inc.SubsidiaryWholly-owned subsidiary with operations controlled from AngioDynamics' New York headquarters. Named alongside parent in port-catheter complaints; jurisdictional dismissals granted based on New York principal place of business.

Timeline

  1. 2021-04

    FDA Class II Recall: Smart Port CT

    FDA issues Class II recall (Z-1466-2021) for AngioDynamics Smart Port CT devices due to catheter separation risks.

  2. 2023-01

    FDA Class II Recall: Vortex MP Port

    FDA issues Class II recall (Z-0132-2023) for AngioDynamics Vortex MP Port devices citing catheter fracture and embolization risks.

  3. 2023-12-07

    Reed v. AngioDynamics: Dismissal Order

    W.D. Missouri Judge Mary Elizabeth Hickey grants in part motion to dismiss in Reed v. AngioDynamics, 2:23-cv-04066-MDH, narrowing claims but allowing core product liability counts to proceed.

  4. 2024-04-23

    Smith v. AngioDynamics: Comment K Ruling

    M.D. Alabama Judge R. Austin Huffaker Jr. applies Comment k to SmartPort device, dismissing design defect claim under AEMLD but preserving failure-to-warn claim. Smith v. AngioDynamics, Inc., 2:24-cv-112-RAH.

  5. 2024-06-28

    Kitchen v. AngioDynamics: OPLA Claims Survive

    N.D. Ohio Judge Dan Aaron Polster denies partial motion to dismiss, allowing Ohio Product Liability Act claims for design defect, failure to warn, and fraudulent concealment to proceed. Kitchen v. AngioDynamics, 1:24-cv-00132.

  6. 2024-10

    JPML Establishes MDL 3125

    Judicial Panel on Multidistrict Litigation transfers and consolidates all federal AngioDynamics/Navilyst port catheter cases to S.D. California as In re AngioDynamics, Inc. and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, MDL No. 3125, before Judge Jinsook Ohta.

  7. 2026-08-04

    Bellwether Selection Deadline

    Deadline for parties to submit nine case selections each for 18-case bellwether discovery pool per MDL 3125 case management protocol. First bellwether trials anticipated mid-2028.

Statute of limitations

MDL 3125 established February 2025: In re: AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, S.D. Cal., Judge Jinsook Ohta. Confirmed device scope: SmartPort, Xcela, Xcela Plus, Vortex, Vortex Dual Port, BioFlo. Exclusively AngioDynamics/Navilyst—screen out Bard/BD PowerPort (MDL 3081). Missouri poses urgent accrual risk given 'capable of ascertainment' standard and Reed dismissal pattern.

⚠ 1 state with critical SOL — act immediately

⚠Missouri

5 years from when damage is capable of ascertainment

Rule: Accrual on 'capable of ascertainment' standard per Reed dismissal; Judge M. Douglas Harpool, W.D. Mo., Dec. 8, 2023

Discovery: Missouri's 'capable of ascertainment' standard predates discovery; inquiry notice events matter

Reed dismissal held claims time-barred at 10+ years; strict accrual analysis bars delayed filings

Alabama

2 years from accrual

Rule: AEMLD claims subject to Comment k unavoidably unsafe product doctrine; Smith v. AngioDynamics, 2:24-cv-112-RAH, M.D. Ala. Apr. 23, 2024

Design defect claims likely barred under Comment k; failure-to-warn claims may survive if adequately pled

California

2 years from discovery of injury

Rule: Discovery rule applies; MDL 3125 situs, S.D. Cal. Judge Jinsook Ohta

Discovery: Discovery of injury and its cause triggers accrual

MDL 3125 transferee court; large plaintiff pool per source [1]

Texas

2 years from accrual

Rule: Tex. Civ. Prac. & Rem. Code § 16.003; tort reform limits damage awards per source [1]

Tort reform caps non-economic damages; verify device type excludes Bard/BD PowerPort

Florida

2-4 years depending on theory

Rule: Products liability 4 years, medical malpractice 2 years; tort reform limits damages per source [1]

Screening critical: implantation-related complications may trigger shorter med-mal SOL

New York

3 years from injury

Rule: N.Y. C.P.L.R. § 214(6); broader recovery allowed per source [1]

Discovery: Discovery of injury triggers accrual

Large plaintiff concentration; no damages cap

Pennsylvania

2 years from discovery

Rule: 42 Pa. C.S. § 5524; significant plaintiff volume per source [1]

Discovery: Accrual upon discovery of injury and causation

No economic damages cap; no statute of repose

StateSOLRuleDiscovery RuleNotes
⚠Missouri5 years from when damage is capable of ascertainmentAccrual on 'capable of ascertainment' standard per Reed dismissal; Judge M. Douglas Harpool, W.D. Mo., Dec. 8, 2023Missouri's 'capable of ascertainment' standard predates discovery; inquiry notice events matterReed dismissal held claims time-barred at 10+ years; strict accrual analysis bars delayed filings
Alabama2 years from accrualAEMLD claims subject to Comment k unavoidably unsafe product doctrine; Smith v. AngioDynamics, 2:24-cv-112-RAH, M.D. Ala. Apr. 23, 2024—Design defect claims likely barred under Comment k; failure-to-warn claims may survive if adequately pled
California2 years from discovery of injuryDiscovery rule applies; MDL 3125 situs, S.D. Cal. Judge Jinsook OhtaDiscovery of injury and its cause triggers accrualMDL 3125 transferee court; large plaintiff pool per source [1]
Texas2 years from accrualTex. Civ. Prac. & Rem. Code § 16.003; tort reform limits damage awards per source [1]—Tort reform caps non-economic damages; verify device type excludes Bard/BD PowerPort
Florida2-4 years depending on theoryProducts liability 4 years, medical malpractice 2 years; tort reform limits damages per source [1]—Screening critical: implantation-related complications may trigger shorter med-mal SOL
New York3 years from injuryN.Y. C.P.L.R. § 214(6); broader recovery allowed per source [1]Discovery of injury triggers accrualLarge plaintiff concentration; no damages cap
Pennsylvania2 years from discovery42 Pa. C.S. § 5524; significant plaintiff volume per source [1]Accrual upon discovery of injury and causationNo economic damages cap; no statute of repose

Live intelligence

AI litigation brief

AngioDynamics Port Catheter remains early-stage / active mdl with 55 current signals in the accepted feed.

Overview

MDL 3125 before Judge Jinsook Ohta in S.D. Cal. remains in early pretrial proceedings with bellwether selection underway. Court granted 60-day extension requiring each side to submit nine representative cases by August 4, 2026, narrowing to four each by December 11, 2026 for final pool of eight trial claims; first bellwether trial unlikely before mid-2028.

Key developments

  • PACER court filing on Aug 10: AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation
  • AboutLawsuits.com news on Aug 7: AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis - AboutLawsuits.com
  • MAUDE FDA alert on Jul 30: MAUDE Filing 50085526: PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
  • PubMed research on Jul 21: Incidence and Timing of Venous Thromboembolism After Implantable Port Placement in Cancer Patients: A Single-Centre Cohort Study.

Trajectory

Court filings and press coverage are both active in MDL 3125, pointing to sustained litigation pressure rather than a one-off headline cycle. 14 live sources are contributing current context.

Editorial intelligence

MDL 3125 should stay on the lead docket watch because it is the primary consolidation vehicle for AngioDynamics Port.

Generated Aug 12, 2026, 2:00 AM UTC

55 events detected

Google News (10)

  • AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis - AboutLawsuits.com

    AboutLawsuits.comAug 7, 2026, 3:00 PM UTC
  • Port Catheter Sepsis Lawsuit Claims Defective SmartPort Implant Caused Infection - AboutLawsuits.com

    AboutLawsuits.comJul 22, 2026, 7:00 AM UTC
  • SmartPort Catheter Lawsuit Claims Defective AngioDynamics Port-a-Cath Caused Infection - AboutLawsuits.com

    AboutLawsuits.comJul 14, 2026, 7:00 AM UTC
  • Vortex Port Lawsuit Claims Defective AngioDynamics Device Caused Infection, Pulmonary Embolism - AboutLawsuits.com

    AboutLawsuits.comJul 7, 2026, 7:00 AM UTC
  • AngioDynamics Port Catheter Lawsuit Claims Woman’s SmartPort Implants Caused Multiple Infections - AboutLawsuits.com

    AboutLawsuits.comJun 23, 2026, 7:00 AM UTC
  • Xcela Port Lawsuit Claims AngioDynamics Catheter Caused Thrombosis - AboutLawsuits.com

    AboutLawsuits.comJun 12, 2026, 7:00 AM UTC
  • Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury - AboutLawsuits.com

    AboutLawsuits.comJun 3, 2026, 7:00 AM UTC
  • SmartPort Surgery Lawsuit Claims AngioDynamics Catheter Fractured Inside Woman’s Body - AboutLawsuits.com

    AboutLawsuits.comMay 15, 2026, 7:00 AM UTC
  • 18 AngioDynamics Port Catheter Lawsuits Will Be Selected for Bellwether Discovery in August 2026 - AboutLawsuits.com

    AboutLawsuits.comMay 5, 2026, 7:00 AM UTC
  • AngioDynamics Catheter Lawsuit Claims SmartPort Device Embedded in Jugular Vein, Caused Embolism - AboutLawsuits.com

    AboutLawsuits.comApr 30, 2026, 7:00 AM UTC
StudyPubMed
Detected Aug 12, 2026, 2:07 AM UTC

Incidence and Timing of Venous Thromboembolism After Implantable Port Placement in Cancer Patients: A Single-Centre Cohort Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis • Kozłowski R • PMID 42478803 • Journal Article.

Confidence 74%Published Jul 21, 2026, 12:00 AM UTCSource →
StudyPubMed
Detected Aug 12, 2026, 2:07 AM UTC

Impact of an Educational Intervention on Nurses' Knowledge of Port Catheter Management: A Quasi-Experimental Pre-Post Study.

Healthcare (Basel, Switzerland) • Mete B • PMID 42512689 • Journal Article.

Confidence 74%Published Jul 18, 2026, 12:00 AM UTCSource →
StudyPubMed
Detected Aug 12, 2026, 2:07 AM UTC

Lessons in IR: Morbidity and Mortality-Sweet Syndrome Mimicking Central Venous Port Infection.

Journal of vascular and interventional radiology : JVIR • Ronald J • PMID 42308596 • Journal Article.

Confidence 74%Published Jun 17, 2026, 12:00 AM UTCSource →
PACERCASD3:26-cv-04558Aug 10, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against All Defendants. Related to MDL Case - 24md3125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21490456.), filed by Paul Johnson. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4558-JO-VET. Judge Jinsook Ohta and Magistrate Judge Valerie E. Tor

PACERCASD3:26-cv-04527Aug 7, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against All Defendants. Related to MDL Case - 24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21486221.), filed by Carol Elaine Scott. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4527-JO-VET. Judge Jinsook Ohta and Magistrate Judge Valer

PACERCASD3:26-cv-04503Aug 6, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21481235.), filed by Maxine Rivera. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4503-JO-VET. Judge Jinsook Ohta an

PACERCASD3:26-cv-04468Aug 5, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against AngioDynamics, Inc., Navilyst Medical, Inc., PFM Medical, Inc.. Related to MDL Case - 24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21473120.), filed by Lisa Killgore. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4468-JO-VET. Ju

PACERCASD3:26-cv-04444Aug 4, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24md3125. ( Filing fee $ 405 receipt number ACASDC-21466534.), filed by Cassandra Owens. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4444-JO-VET. Judge Jinsook Ohta and Magist

PACERCASD3:26-cv-04426Aug 3, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24md3125. ( Filing fee $ 405 receipt number ACASDC-21464144.), filed by Michael Troch. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4426-JO-VET. Judge Jinsook Ohta and Magistra

PACERCASD3:26-cv-04425Aug 3, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., PFM Medical, Inc.. Related to MDL Case - 24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21463582.), filed by Kevin Feingold. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4425-JO-VET. Judge Jinsook Ohta and Ma

PACERCASD3:26-cv-04393Jul 31, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angio Dynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24md3125. ( Filing fee $ 405 receipt number ACASDC-21457473.), filed by Susan Bright. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4393-JO-VET. Judge Jinsook Ohta and Magistra

PACERCASD3:26-cv-04389Jul 31, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24md3125. ( Filing fee $ 405 receipt number ACASDC-21455324.), filed by Jennifer Smith. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4389-JO-VET. Judge Jinsook Ohta and Magistr

PACERCASD3:26-cv-04361Jul 30, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24md30125. ( Filing fee $ 405 receipt number ACASDC-21450191.), filed by Charlene M. Hayes. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-4361-JO-VET. Judge Jinsook Ohta and Mag

Sign in to view all 17 filings

Workbench

Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.

LexGenius Ranking

100Score

Court, news, and regulatory activity are elevated

Evidence20 / 20
Momentum20 / 20
Exposure20 / 20
Regulatory20 / 20
Legal20 / 20

Monitoring

Live

monitoring

Last: Aug 12, 2026, 2:00 AM UTC

Next: —

Source Monitoring

PACER

3m 54s

PACER

2m 54s

Google News

3m 54s

MAUDE

8m 54s

PubMed

23m 54s

Event feed

55

events detected

Google NewsPACERMAUDEPubMed

AI Brief

AngioDynamics Port Catheter remains early-stage / active mdl with 55 current signals in the accepted feed.

Overview

MDL 3125 before Judge Jinsook Ohta in S.D. Cal. remains in early pretrial proceedings with bellwether selection underway. Court granted 60-day extension requiring each side to submit nine representative cases by August 4, 2026, narrowing to four each by December 11, 2026 for final pool of eight trial claims; first bellwether trial unlikely before mid-2028.

Key developments

PACER court filing on Aug 10: AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation. ‖ AboutLawsuits.com news on Aug 7: AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis - AboutLawsuits.com. ‖ MAUDE FDA alert on Jul 30: MAUDE Filing 50085526: PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR. ‖ PubMed research on Jul 21: Incidence and Timing of Venous Thromboembolism After Implantable Port Placement in Cancer Patients: A Single-Centre Cohort Study..

Generated Aug 12, 2026, 2:00 AM UTC

Tracked MDLs

MDL 3125

S.D. Cal.

AngioDynamics/Navilyst port catheter products liability

← Previous

Bard PowerPort

Tracks PowerPort device litigation, catheter safety reporting, and related medical literature.

Next →

EtO Sterilization

Follows ethylene oxide emissions litigation, sterilization-facility enforcement, and environmental-health reporting.